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I.  PRD Risk Title: Risk of Adverse Health Effects Due to Host-Microorganism 
Interactions 
 
II.  Executive Summary 
 
While preventive measures limit the presence of many medically significant microorganisms 
during spaceflight missions, microbial infection of crewmembers cannot be completely prevented. 
Spaceflight experiments over the past 50 years have demonstrated a unique microbial response to 
spaceflight culture, although the mechanisms behind those responses and their operational 
relevance were unclear. In 2007, the operational importance of these microbial responses was 
emphasized as the results of an experiment aboard STS-115 demonstrated that the enteric pathogen 
Salmonella enterica serovar Typhimurium (S. Typhimurium) increased in virulence in a murine 
model of infection. The experiment was reproduced in 2008 aboard STS-123 confirming this 
finding. In response to these findings, the Institute of Medicine of the National Academies 
recommended that NASA investigate this risk and its potential impact on the health of the crew 
during spaceflight. NASA assigned this risk to the Human Research Program. To better understand 
this risk, evidence has been collected and reported from both spaceflight analog systems and actual 
spaceflight including Mir, Space Shuttle, and ISS missions. Although the performance of virulence 
studies during spaceflight are challenging and often impractical, additional information has been 
and continues to be collected to better understand the risk to crew health. Still, the uncertainty 
concerning the extent and severity of these alterations in host-microorganism interactions is very 
large and requires more investigation as the focus of human spaceflight shifts to longer-duration 
exploration class missions. 
III.  Introduction 
 
Transfer of microorganisms from person to person are common in closed habitats such as 
spacecraft (1, 2)1, including the spread of opportunistic organisms impacting the overall risk to 
astronaut health during spaceflight missions of extended duration. Current spaceflight data clearly 
demonstrates alterations in aspects of the crew immune system during spaceflight (3, 4). Latent 
viral reactivation has been used as a biomarker for reduced immunity during ground-based and 
spaceflight research activities and represents an additional route of infection (5-12). In addition, 
bacteria and fungi have been demonstrated to increase virulence and/or virulence characteristics 
during Space Shuttle and ISS spaceflight experiments (6, 10, 13-17). In this review, we identify 
evidence of molecular-genetic and phenotypic alterations in microorganisms during spaceflight 
and ground-based spaceflight analog models. The background information will be presented that 
outlines the recommendations for investigation, overview of spaceflight and ground-based 
research including animal models.  
A. Identifying the need for investigation. In 2008 the Institute of Medicine (IOM) of the 
National Academies reviewed the Human Research Program Evidence Book of the “Risk 
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of Crew Adverse Health Event Due to Altered Immune Response.”2 The IOM cited 
research from a flight experiment by Nickerson and colleagues aboard STS-115, which 
indicated that the enteric pathogen, S. Typhimurium had become more virulent when 
cultured during spaceflight. The IOM recommended NASA “Develop evidence books on 
additional risks, including alterations in microbe and host interactions…” In November 
2008, a risk entitled, “Risk of Adverse Health Effects Due to Alterations in Host-
Microorganism Interactions,” was added to the Human Research Program’s Integrated 
Research Plan to determine the likelihood and consequences of alterations in microbial 
interactions with the crew and their environment that could impact their health and 
performance. 
B. Flight experiments used to study host-microbe interactions. While several experiments 
have been performed in spaceflight to assess the effects of this unique environment on 
microbes, there are several factors that complicate the evaluation and comparison of the 
resulting data. Key findings of microbial spaceflight studies that impact our understanding 
of medically significant microorganisms are listed in Appendix A. Some of these 
confounding elements include (a) the wide variety of organisms that have been studied 
including motile versus non-motile bacteria; (b) the different spaceflight parameters that 
have been used (e.g., differences in lengths of missions, sample handling – fixed or frozen, 
in-flight centrifuged 1g controls versus ground 1g controls); and (c) differences in growth 
media used (e.g., minimal versus rich media or liquid versus solid media). These factors 
will be discussed in this Evidence Report where appropriate. It is also clear that in spite of 
these differences, the space environment affects microbes differently than traditionally 
observed in the Earth environment, and these changes must be understood to ensure the 
safety of humans during long-duration space missions.  
C. Earth-based cell culture systems used to study host-microbe interactions. While 
spaceflight is the ultimate platform for performing experiments to determine alterations in 
microbial responses and host-pathogen interactions, spaceflight research is constrained by 
high costs, inconsistent flight availability, minimal in-flight analytical equipment, as well 
as limitations in power usage, payload weight and volume, and crew time. Thus, ground-
based analogs (relevant findings summarized in Appendix B) have been developed to 
evaluate alterations in microbial responses to these conditions (18). These analogs do not 
remove gravity from the system, but instead develop an environment that reflects many of 
the secondary effects observed in microgravity (decreased mass transfer, lower fluid shear, 
etc.). Most all of these analogs rely on the continuous sedimentation of microbial cultures 
in a growth medium. The simplest system is the clinostat, which is a cylindrical tube 
completely filled with media (no bubbles, i.e., “zero headspace”), that is rotated 
perpendicular to the gravitational force vector (19). Likewise, a more complex system 
designed by NASA, called the rotating wall vessel (RWV), has been used extensively since 
the mid-1990s (Figure 1). The RWV is also an optimized form of suspension culture and 
consists of a hollow disk or cylinder that is completely filled with medium and rotates on 
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an axis perpendicular to 
the gravitational force 
vector. Under these 
culture conditions, the 
cells are maintained in 
suspension as the RWV 
is rotated and a sustained 
low-shear environment 
for cell growth is 
achieved (18). Exchange 
of nutrients and localized 
“mixing” of the 
microenvironment is 
facilitated by the 
constant falling of the 
cells through the local 
fluid environment and 
the gentle rotation of the 
culture medium. Unlike 
the clinostat, a gas-
permeable membrane on 
one side of the RWV allows constant air exchange during growth. Data from previous 
research on S. Typhimurium indicated that the enhanced virulence observed during 
spaceflight was also observed at a similar trend and magnitude to virulence changes 
imparted by culture in the RWV (15, 16, 20). Similar trends in gene expression and 
regulation were also observed (15, 21). 
 
Other microbial culture spaceflight analogs have been reported, such as the random 
positioning machine (RPM) and the use of diamagnetic levitation (22). The RPM also 
suspends microorganisms in growth media; however, this suspension is maintained by 
randomly adjusting the movement of the bioreactor. Diamagnetic levitation relies on a 
strong magnetic field to levitate microbial cultures, and thus reproduce aspects of 
microgravity. As with all spaceflight analogs, the fidelity of these and other culture devices 
to reproduce culture during spaceflight is not completely known as the mechanisms driving 
the alterations in microbial response are unclear. 
D. The need for human surrogate models. The need for having animal models of microbial 
infection is based on the necessity of having an experimental species whose inflammatory 
and pathological response closely resembles the human host. In addition, animal models 
that can be manipulated genetically provide a tremendous advantage to dissect out the 
underlying molecular mechanisms. Additional requirements of an excellent animal model 
are reproducibility of the pathological response and availability of a wide range of 
molecular/biological targets that can be used to thwart or aggravate the response or design 
effective countermeasures. Depending on the infection and type of study, mammalian 
animal models have proven to be useful in terrestrial experiments. Much of our present 
knowledge about the immune system in space comes from studies conducted on space-
Figure 1. Rotating wall vessel (RWV) developed by 
NASA and used during ground-based microbiology 
experiments.  Image: NASA 
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flown mice (23-27). Moreover, to test the pathological potential of spaceflight conditions, 
murine models have been used to evaluate bacteria grown in space (15, 16). Such studies 
have looked at survival, local and systemic inflammation, and pathophysiology of organs. 
This topic is discussed in detail later in this report. Hind-limb unloading is a widely used 
ground-based model of simulated microgravity in mice and has been used to investigate 
some of the effects of spaceflight on microbial infection (28, 29).  
 
Some evidence on potential changes in the host response during infection was obtained by 
challenging Drosophila melanogaster (fruit fly) after return from a 12-day spaceflight 
mission on STS 121 with Escherichia coli (E. coli)  (30). The study reported that adult flies 
were able to clear E. coli infection postflight but showed differences in the kinetics and 
levels of antimicrobial peptide (AMP) gene expression when compared to the matched 
ground-control flies. 
 
Spaceflight infection studies where the host and pathogen are both in microgravity during 
spaceflight are difficult to perform and virulence data has not been reported to date. Even 
though mice are relatively small, the number of mice that could be infected during 
spaceflight is extremely limited due to space and upmass constraints. As such, other models 
enabling a greater sample size are being investigated. For example, virulence studies using 
the nematode, Caenorhabditis elegans, as a human surrogate model of infection with S. 
Typhimurium have recently been completed aboard the ISS. The results of the experiment, 
designated as Micro-5, are being tracked for future inclusion in this report. 
 
While animal models provide excellent insight into the infection process, reductionist 
tissue culture models are also commonly used to study the infection process. Accordingly, 
human tissue culture models have also been investigated for use as infection models during 
spaceflight. In 2010, the flight experiment designated “Space Tissue Loss, IMMUNE” flew 
aboard STS-131 and was the first infection of human tissue culture cells by a pathogen to 
occur on orbit. The potential of this model is intriguing as mammalian cells cultured during 
spaceflight have been demonstrated to develop a three dimensional architecture that 
reproduces many in vivo characteristics (31). Indeed, these models have been demonstrated 
to reproduce in vivo characteristics that have not been observed using traditional two 
dimensional, monolayer culture (32). 
IV.  Evidence 
 
Alterations in microbial responses to spaceflight culture have been well-documented over the past 
50 years (18, 33-35). An overview of key findings can be found in Appendices A and B. This 
Evidence Report will focus only on those responses that substantially impact this HRP risk. The 
Risk of Adverse Health Effects Due to Host-Microorganism Interactions works with other 
disciplines to gather information and determine the impact to the human as a whole. For example, 
a large body of evidence indicates dysfunction of aspects of the crewmember’s immune system 
during spaceflight missions. This evidence is described in the HRP evidence report addressing 
“Risk of Crew Adverse Health Event Due to Altered Immune Response”3. Collaborations with the 
                                                 
3 http://humanresearchroadmap.nasa.gov/evidence/reports/Immune_2015-05.pdf?rnd=0.22291305066222 
  5 
Immunology discipline are critical to understand the impact the alterations in microbial virulence 
have on the crewmembers and how to mitigate their effects. In addition, work continues with food 
science and nutrition to prevent food spoilage microorganisms, and to incorporate beneficial 
organisms into the food system. Future collaboration efforts have been identified with the 
Pharmacology discipline to understand the impact of spaceflight on medications and efficacy 
against microorganisms. The expertise in the radiation health group are used to understand the 
impact of radiation on microorganisms in the environment and in the human system. Microbial 
identification and evaluation technology continues to evolve and is monitored for spaceflight 
applicability in collaboration with the spaceflight medical capabilities group. The current evidence, 
collaborations and future planned research utilize the ISS as a platform to determine the risk and 
mitigations required for longer-duration exploration class missions.  
 
A. Spaceflight Evidence 
  
1. Micro 1: We need to determine the efficacy of current countermeasures and the need 
for countermeasure development based on changes in microbial populations and 
characteristics.  
The primary post-infection countermeasure during spaceflight is the use of antibiotics; 
however, several spaceflight experiments have provided evidence suggesting 
alterations in antibiotic resistance when microorganisms are cultured during 
spaceflight. During the Cytos 2 experiment aboard Salyut 7 in 1982, the minimum 
inhibitory concentration of oxacillin, chloramphenicol, and erythromycin for 
Staphylococcus aureus (S. aureus) and of colistin and kanamycin for E. coli were 
compared to those of ground controls (36). These early results indicated an increased 
resistance of both S. aureus and E. coli to all antibiotics used in this experiment (36). 
However, the observed alterations in microbial antibiotic resistance during spaceflight 
may be transient and lost when the microbe has returned to Earth, as attempts to 
reproduce these changes after return to Earth have been unsuccessful (37). Spaceflight 
experiments culturing E. coli during STS-69 and STS-73 suggested gentamicin on agar 
slants that were flown was as effective as and possibly more effective than the antibiotic 
on ground-based control cultures (38). In 1999, Juegensmeyer et al. observed both 
increased sensitivity and resistance by cultures of S. aureus, Pseudomonas aeruginosa 
(P. aeruginosa), Bacillus subtilis (B. subtilis), and E. coli that had been re-grown after 
having been on the Mir space station for 4 months (39). While these experiments 
suggest spaceflight-associated changes in microbial response to antibiotics, the 
information is not adequate to be predictive about reproducibility with the selected 
microorganisms, the impact of antibiotics on other microorganisms, or the actual 
microbial response during exposure in a human host. 
 
Countermeasures directed at minimizing the impact of viral pathogens, such as 
vaccinations, are being evaluated. For example, preflight vaccination against the 
varicella-zoster virus (VZV) prevents VZV reactivation and shedding of live, 
infectious virus into the ISS environment. Even though there are no vaccines currently 
for the other herpes viruses, countermeasures focused on stress reduction have shown 
promising results (40, 41).  
  6 
 
The current research plan includes foundational research to understand the need for 
countermeasure development. After the foundational studies have been completed, 
future areas of study include: 
 Evaluation of in-flight efficacy of preventive agents and countermeasures such as 
disinfectants and antibiotics  
 Impact of spaceflight-related alterations in the crew microbiome on antimicrobial 
efficacy.  
2. Micro 2: We need to determine if spaceflight induces changes in diversity, 
concentration, and/or characteristics of medically significant microorganisms 
associated with the crew and environment aboard the ISS that could affect crew 
health.  
Stringent microbiological monitoring of spacecraft (Figure 2) has been performed 
operationally aboard NASA spacecraft 
throughout the human spaceflight 
program (33, 42). Additional spaceflight 
experiments have also provided greater 
detailed information by investigating 
specific niches aboard spacecraft or using 
alternative methodologies beyond the 
culture-based isolation historically used 
(43). Generally, the data indicate that the 
potable water, air, and surfaces to which 
the crew are exposed are free of obligate 
pathogens; however, opportunistic 
pathogens such as P. aeruginosa, 
Stenotrophomonas maltophilia, and S. 
aureus are not uncommon (42, 44). In addition, identification of microorganisms 
collected from free-floating water behind panels indicated several potentially medically 
significant organisms not commonly isolated during standard operational monitoring, 
including Legionella species, and Serratia marcescens (S. Marcescens), and E. coli 
(45). Further microscopic examination of these samples revealed the presence of 
amoeba resembling Acanthamoeba or Hartmanella species and ciliated protozoa 
resembling Stylonychia species (45).  
 
Figure 2. Astronaut performing 
routine microbiology monitoring 
during spaceflight. Image: NASA 
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Spaceflight food (Figure 3) is currently provided for missions in a shelf stable form for 
storage at ambient temperature (46). As such, microbiological contamination control, 
including stringent microbial monitoring, is maintained. While the incidence of 
contamination is low, preflight analyses 
of food samples have indicated the 
presence of organisms such as S. 
Typhimurium, S. aureus, Enterobacter 
cloacae and Enterobacter sakazakii 
(unpublished data). Contaminated lots are 
removed before shipment for flight; 
however, these findings suggest a 
potential route of infection to the crew. 
Future spaceflight missions may also 
provide food with potentially high levels 
of microorganisms, such as freshly grown 
crops or foods with probiotic organisms 
to promote astronaut health. 
The production and monitoring requirements of these foods are only beginning to be 
evaluated; initial findings can be found in the HRP report, Development of Spaceflight 
Foods with High Microbial Concentrations4.  
 
For spaceflight missions, the primary source of microorganisms is the crew. Selected 
preflight microbiological monitoring is performed prior to launch, with testing based 
on the mission design. One key aspect of preflight operations is NASA’s Flight Crew 
Health Stabilization Program, which was established during the Apollo Program in 
response to problems with incidences of infectious illness (47). The focus of the 
program involves reducing the exposure of flight crews to groups and individuals that 
are at high risk of harboring infectious disease (e.g., large crowds, small children) 
beginning approximately 10 days before launch. 
 
The microbiome is an important part of the crew health and current spaceflight 
investigations to understand the alterations in the microbiome are in progress. Previous 
evaluations of Bifidobacterium in cosmonauts by Goncharova noted preflight decreases 
in bifidobacteria and alterations in acid formation during flight (48).  
 
Astronauts shed Epstein-Barr virus (EBV) in saliva before, during, and after 
spaceflight. Frequency of shedding in astronauts was several times higher than control 
subjects, but shedding during flight was approximately 10 times higher than before or 
after flight. Surprisingly, even though astronauts did occasionally present with cold 
sores, occurrence of herpes simplex (HSV-1) in saliva was not common. VZV was not 
present in the saliva of astronauts before flight or in matching ground-control subjects. 
However, VZV did shed in ~50% of crewmembers during flight and continued up to 
~5 days after landing. Aboard the ISS, approximately 60% of astronauts shed VZV 
during the flight phase and some can shed the virus at least 30 days after flight. A few 
cases of zoster have occurred either before, during, or after spaceflight. Mehta and 
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Figure 3. Examples of spaceflight 
food. Image: NASA 
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Pierson showed that 47% of Space Shuttle astronauts shed cytomegalovirus (CMV) in 
urine during spaceflight and continued for 2 weeks after flight. Whereas, less than 1% 
of control subjects shed CMV (10). Follow-up studies showed that 73% of ISS 
astronauts shed CMV and shedding continued for 30 days after landing. In one study 
of 71 astronauts, 77% were seropositive. 
 
Routine microbial monitoring activities are performed operationally to evaluate air, 
surface and water supplies during spaceflight operations. In addition, cargo and 
supplies are sampled to minimize the risk of microbial contamination. There is an 
ongoing effort to evaluate the data collected during routine microbial monitoring and 
reported incidence of crewmember medical issues.  
 
The current research plan includes foundational research to understand the microbes 
present in the spaceflight environment. After the foundational studies have been 
completed, future areas of study include: 
 Spaceflight alterations of fungal diversity  
 Impact of spaceflight radiation exposure on crew microbiome. Note: Ground-
based radiation experiments should use similar exposure methods and  simulate 
the spaceflight environment (such as low earth orbit or deep space) as closely 
as possible. 
 
3. Micro 3: We need to determine which medically significant microorganisms display 
changes in the dose-response profiles in response to the spaceflight environment that 
could affect crew health. 
S. Typhimurium is an obligate enteric 
pathogen with a potential to infect the 
crew during a spaceflight mission 
through the spaceflight food system. 
Extensive ground-based studies of the 
response of S. Typhimurium to the 
spaceflight analog environment in the 
RWV indicated an increase in 
microbial virulence using a murine 
model of infection (20). The 
microorganisms also displayed altered 
stress responses, gene expression, and survival in macrophage cells (20, 21). Building 
upon this information, the MICROBE flight experiment was performed in 2006 aboard 
the STS-115 mission. In this experiment, S. Typhimurium was grown during flight and 
compared to identically cultured ground controls (15). The cultures were either placed 
in an RNA fixative during flight or returned as live cultures for virulence testing. The 
cultures grown aboard the Space Shuttle displayed an extracellular matrix that was not 
seen in the ground controls. Evaluation of the gene expression indicated 167 genes and 
73 proteins were differentially regulated compared to ground controls, with the 
conserved RNA-binding protein Hfq identified as a likely global regulator involved in 
the response to this environment. Subsequent experiments using the RWV bioreactor 
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supported the necessity of Hfq in the spaceflight/spaceflight-analog response (15). In 
addition, cultures grown in a Lennox Broth medium during flight caused a reduced 
time-to-death, increased percent mortality, and displayed a 2.7 fold lower LD50 (lethal 
dose required to kill 50% of the mice) in a murine infection model when compared to 
inoculation with ground-control cultures. This experiment produced several key 
findings including: (1) the experiment clearly indicated alterations in the expected 
dose-response curves with implications for the microbial risk assessment of infection 
potential for the crew during a mission; (2) the experiment provided the first insight 
into a molecular mechanism behind the alterations of microorganisms during 
spaceflight culture; and (3) the virulence and gene expression results from the 
spaceflight experiment paralleled the 
trends observed with the RWV 
spaceflight analog (20), supporting 
this bioreactor as an indicator of 
potential microbial alterations during 
spaceflight.  
 
In 2008, Nickerson and her colleagues 
reproduced the evaluation of 
virulence changes using S. Typhimurium cultured aboard STS-123 (16). Figure 4 
shows a crewmember performing spaceflight operations. Cultures grown in a Lennox 
Broth medium during flight displayed a 6.9 fold lower LD50 in a murine model when 
compared to inoculation with ground-control cultures. 
 
During the MICROBE experiment, the global transcriptional responses of P. 
aeruginosa to spaceflight culture were also investigated (14). P. aeruginosa responded 
to spaceflight conditions through differential regulation of 167 genes and 28 proteins, 
with Hfq as a global transcriptional regulator. Key virulence-related genes that were 
differentially regulated included the lectin genes, lecA and lecB, and the gene for 
rhamnosyltransferase (rhlA), which is involved in rhamnolipid production. As with S. 
Typhimurium, the transcriptional response of spaceflight-grown P. aeruginosa 
displayed many similarities to trends observed during culture of P. aeruginosa in the 
RWV bioreactor (49, 50).  
 
In a separate set of spaceflight experiments, Kim et al. investigated biofilm formation 
of P. aeruginosa during spaceflight (51). This research team found that the biofilm 
architecture was substantially different compared to Earth-grown controls. While the 
medical implications of this finding are unclear, it is an excellent example of one of 
many ways in which microorganisms can be altered during spaceflight.  
 
Figure 4. Astronaut Dominic Gorie 
manually activates the Group Activation 
Pack (GAP) hardware containing the 
MDRV spaceflight experiment aboard 
STS-123 to better understand bacterial 
responses to the spaceflight environment. 
Image: NASA 
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In addition, Pierson and Mehta (5, 6) have 
studied latent herpes viruses in astronauts 
for nearly 20 years in spacecraft (Space 
Shuttle, Soyuz, Mir, and ISS). They found 
that EBV, VZV, and CMV reactivate and 
are shed in saliva (EBV, VZV) or urine 
(CMV) at levels that far exceed control 
subjects (9, 10). Figure 5 shows an image 
of saliva being collected during spaceflight 
saliva collection. The viruses remain latent 
until the immune system, specifically T-
cell function, decreases to levels that can 
no longer control reactivation of the latent 
viruses.  
 
The current research plan includes foundational research to understand which 
medically significant microorganisms display virulence changes during spaceflight. 
After the foundational studies have been completed, future areas of study include: 
 Defining the impact of radiation on microbial virulence 
 Does spaceflight-associated virulence change when organisms are evaluated as 
co-cultures? 
 Does spaceflight alter virulence in medically significant fungi? 
4. Micro 4: We need to determine how physical stimuli specific to the spaceflight 
environment, such as microgravity, induce unique changes in the dose-response 
profiles of expected medically significant microorganisms.  
The stimulus/stimuli during spaceflight culture that initiate a change in bacterial and 
fungal response and the molecular-genetic and biochemical processes that result during 
this response have not been identified, although some evidence is available. Kacena et 
al. found that growth on semisolid agar negated changes in enhanced microbial growth 
noted in liquid cultures, suggesting that a physical artifact from the agar influenced the 
bacterial response (52). Wilson et al. found that the change in S. Typhimurium 
virulence identified when cultures were grown in Lennox Broth was not observed when 
spaceflight cultures were grown in a simple salt, M9 medium or in Lennox Broth 
supplemented with 5 key inorganic salts used in the M9 formulation (16). As 
mechanosensitive ion channels that trigger ion transport exist in bacteria (53), mass 
transfer during spaceflight or alterations in ion permeability at the cell membrane are 
also potential factors that could impact the spaceflight-associated response. Notably, 
both the Kacena and Wilson studies provide evidence that microgravity alone does not 
stimulate unique bacterial and fungal responses. Rather, secondary effects of decreased 
gravity (eg, changes in mass transfer or fluidic shear), are likely responsible for the 
microbial response. 
 
Another key piece of evidence in understanding the bacterial and fungal response to 
spaceflight culture is the observation by Wilson et al. of the Hfq regulation of a large 
number of differentially regulated genes in spaceflight-cultured S. Typhimurium (15). 
Figure 5. Astronaut Doug Wheelock 
collecting saliva sample during 
spaceflight operations. Image: NASA 
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This report suggests that the microbial responses that are being documented are aligned 
with known regulatory pathways (as opposed to random dysfunction of the organism). 
How the organism uses such a response on Earth is unclear. Importantly, this regulatory 
protein also substantially impacted spaceflight induced differential gene expression in 
P. aeruginosa (14). 
 
An additional consideration in regard to the cause(s) behind microbial alterations 
during spaceflight culture was provided by Kim et al. in a spaceflight study 
investigating P. aeruginosa, which displayed higher final bacterial concentrations in 
spaceflight culture compared to ground controls (54). Previous articles proposed that 
motility may play a large role in the unique responses of microorganisms to spaceflight 
culture (55). To test this hypothesis, Kim et al. compared final cell concentrations of a 
wild-type P. aeruginosa and a mutant deficient in swimming motility to their respective 
ground controls. Similar increases in final cell concentrations of both organisms were 
observed compared to their respective controls, suggesting motility did not play an 
important role in the response (54). 
 
Also notable in the discussion about stimulus and response to spaceflight culture is that 
the data from current spaceflight experiments does not inherently suggest that the 
alterations observed in spaceflight-cultured microorganisms are transient or represent 
heritable changes. The environmental conditions during spaceflight missions, 
especially those beyond low-Earth orbit, could impact the selective pressure to increase 
and stabilize heritable mutations in the microbial genomes. These environmental 
conditions include changes in the intensity and type of radiation as well as gravity 
compared to terrestrial conditions. Spaceflight studies exploring this possibility have 
been limited in part due to the resources necessary to perform long-duration growth 
experiments. However, some evidence suggests a change in the normally expected 
mutation rate may occur. Ciferri et al. evaluated changes in conjugation, transduction, 
and transformation using E. coli  cultures (56). While the rate of pairing did not appear 
to be affected during conjugation in spaceflight cultures, they did note that the pairs 
were being held longer, which they attributed to the absence of external disruptive 
forces. No differences were reported for transduction, and the results for transformation 
were inconclusive. The extent of heritable changes in the microbial genome that are 
induced by spaceflight radiation and microgravity is unclear. While several spaceflight 
experiments have investigated aspects of this topic (57-59), no general trend or 
mechanism has been defined based on current findings. 
 
To fully understand the impact of stimulus/stimuli on microorganisms and their 
implications on crew health, an understanding of the biochemical responses may enable 
insight into which organisms may be altered and how the alteration will be manifested 
in each organism. Alterations in the biochemical pathways of microorganisms have 
been investigated in multiple spaceflight studies. For example, alterations in the 
production of the secondary metabolite, Actinomycin D, were measured by Benoit et 
al. from Streptomyces plicatus grown in gas-permeable culture bags aboard the ISS 
(60). Unfortunately, all cell concentrations over time were not available, and the 
authors speculated that these changes may have been the result of differences in growth 
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profiles of spaceflight and ground-based cultures that had been previously reported by 
Mennigmann et al. in previous studies (61). 
 
Research documenting spaceflight-associated latent virus reactivation in herpes viruses 
began with EBV evaluation in Space Shuttle astronauts (5). Glaser (62-65) 
demonstrated decreased cellular immunity and increased antibodies to EBV in 
chronically stressed individuals. Studies have linked psychological stress with onset 
and severity of infectious mononucleosis (66). Studies (6) demonstrated increased 
inflammatory cytokines in astronauts shedding latent viruses.  
 
The current research plan includes foundational research to understand the mechanism 
of alterations in microbial virulence during spaceflight. After the foundational studies 
have been completed, future areas of study include: 
 How does spaceflight impact the risk for fungal disease? 
 How does partial or fractional gravity impact virulence?  
 Do changes or differences in the host such as immune function, fluid shift, 
microbiome, sex/gender, or prior infection impact the risk of host-pathogen 
interaction?  
 Further characterization of genetic and resulting gene expression and 
phenotypic changes of microorganisms during spaceflight.  
5. Micro 5: Current microbial standards identifying microbial risk limits need to be 
updated and microbial requirements need to be developed to include new 
technologies and future mission scenarios. 
Future exploration class missions will require the use of advanced microbial 
identification technologies. Currently, microbial enumeration of environmental 
samples is performed during space flight operations and samples are returned to the 
ground for microbial identification (67). The specifications developed for microbial 
testing of space foods are in compliance with the United States Food and Drug 
Administration (FDA) hazard analysis and critical control points (HACCP) 
requirements. Specifications are maintained in accordance of International Food 
Standards and updated as required. The current microbial requirements were refined 
based on a series of forums with input from experts from industry, government and 
academia (68). The requirements are reviewed regularly to determine applicability to 
current and future planned spaceflight missions. A continuous effort to identify and 
understand new technology continues to determine the best methods for microbial 
identification during spaceflight operations including exploration class missions that 
will require greater autonomy due to communications delays and limited resupply.  
 
The current research plan includes foundational research to develop future microbial 
requirements and hardware. After the foundational studies have been completed, future 
areas of study include microbial risk assessment and clinical relevance.   
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B. Ground-based Evidence 
1. Micro 1: We need to determine the efficacy of current countermeasures and the need 
for countermeasure development based on changes in microbial populations and 
characteristics.  
The impact of spaceflight on countermeasures, such as antibiotics, and the resulting 
changes in efficacy is a concern for long-duration spaceflight. The Human Research 
Program supported a pilot investigation to determine initial characterization of 
alterations in effectiveness of selected antibiotics using the RWV5. This study 
identified potential alterations in efficacy and the results suggest the best approach for 
applied forward work is evaluating an in vivo system during spaceflight, including 
human and rodent studies. 
2. Micro 2: We need to determine if spaceflight induces changes in diversity, 
concentration, and/or characteristics of medically significant microorganisms 
associated with the crew and environment aboard the International Space Station 
that could affect crew health.  
While the identification, enumeration, and distribution of medically significant 
microorganisms in spacecraft has been extensively monitored since the Apollo 
Program, data from closed chamber analogs, such as the Russian Mars-500 mission 
(69) or Antarctic habitation (70, 71), have also been collected to supplement these 
findings. One example of a well-controlled system was the Lunar-Mars Life Support 
Test Project (LMLSTP) consisting of 4 tests of individuals living in an 
environmentally-closed chamber for up to 91 days (72). Microbiological monitoring 
results during the LMLSTP displayed microbiota commonly isolated from many 
terrestrial habitats, with microorganisms in the chamber environment reflecting the 
human and/or plant inhabitants.  
3. Micro 3: We need to determine which medically significant microorganisms display 
changes in the dose-response profiles in response to the spaceflight environment that 
could affect crew health.  
As mentioned previously, the first pathogenic microorganism to be extensively studied 
when grown in the spaceflight analog environment of the RWV was S. Typhimurium. 
These early studies indicated that S. Typhimurium grown in the RWV were more 
virulent and were recovered in higher numbers from the murine spleen and liver 
following oral infection of a murine model compared to organisms grown under a 
normal gravity control (20). S. Typhimurium grown in the RWV also displayed altered 
stress responses and survival in macrophage cells (20, 21). A comparison of microarray 
data from the RWV and control cultures indicated 163 differentially expressed genes 
distributed throughout the chromosome, representing functionally diverse groups 
including transcriptional regulators, virulence factors, lipopolysaccharide biosynthetic 
enzymes, iron-utilization enzymes, and proteins of unknown function (21). These 
studies with S. Typhimurium prompted other investigators to study the impact of RWV 
culture on a variety of microorganisms.  
                                                 
5 https://taskbook.nasaprs.com/publication/index.cfm?action=public_query_taskbook_content&TASKID=9315 
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Numerous strains of E. coli have been cultured in the RWV. Investigations with E. coli 
MG1655 cultured in Luria Broth displayed decreased growth, the down-regulation of 
14 genes, and no discernable changes to environmental stressors, such as resistance to 
acid and osmotic stress when compared to controls (73). When this same strain was 
cultured in a minimal salts media, no difference in growth was observed and 35 genes 
were differentially expressed (73). Conversely, culture of E. coli AMS6 in minimal 
media demonstrated an increased resistance to acid and osmotic stress in response to 
the low-shear conditions (74). Interestingly, culture of this strain in the RWV displayed 
significantly higher biofilm production on glass microcarrier beads placed in the reactor 
(75). Investigation of the response of adherent-invasive E. coli O83:H1 to culture in 
the RWV indicated this organism did not change growth, acid or osmotic resistance; 
however, it did display an increased resistance to thermal and oxidative stress in 
minimal media (76). Interestingly, low-shear-cultured E. coli O83:H1 displayed 
increased adherence to epithelial cells although invasion rates were unchanged as 
compared to controls (76). 
 
P. aeruginosa cultured in the RWV displayed distinct changes in its biofilm 
architecture compared to controls (49), which could impact its virulence and antibiotic 
resistance. In addition, RWV culture of P. aeruginosa appears to influence the rhl N-
butanoyl-L-homoserine lactone (C4-HSL) directed quorum sensing (QS) system, 
increasing the production of rhamnolipids, and potentially having an impact on the 
virulence of the organism (49). Analysis of gene expression data also identified a role 
for the global regulatory protein, Hfq, as seen in S. Typhimurium (50).  
 
Other organisms beyond gram-negative pathogens have been evaluated using the 
RWV. The response of S. aureus to RWV culture has been the most thoroughly studied 
among Gram-positive microorganisms. Interestingly, while gene expression appears to 
be regulated by Hfq (77), as seen with S. Typhimurium and P. aeruginosa, virulence 
characteristics, such as staphyloxanthin production and hemolytic activity appear to be 
repressed (77, 78). Culture of Streptococcus pneumoniae in the RWV has also been 
studied as 41 genes were reported to be differentially regulated (79). The pathogenic 
yeast Candida albicans displayed random budding patterns and enhanced filamentous 
growth when cultured in the RWV, suggesting a more pathogenic phenotype (80). 
4. Micro 4: We need to determine how physical stimuli specific to the spaceflight 
environment, such as microgravity, induce unique changes in the dose-response 
profiles of expected medically significant microorganisms.  
As mentioned above, after gene expression data from spaceflight culture of S. 
Typhimurium indicated an association of the differentially expressed genes with the 
global regulatory protein, Hfq, these investigators used the RWV system to show 
corroborating evidence by comparing the stress response and macrophage survival of 
a wild type and an hfq mutant strain (15). A similar approach with the RWV was used 
to corroborate the impact of high inorganic ion concentrations on the spaceflight culture 
response of S. Typhimurium, even to the point of suggesting inorganic phosphate as a 
potential candidate as the causative agent (16). The finding by Wilson et al. is not 
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completely surprising as earlier work in the RWV indicated that the ferric uptake 
regulator gene (Fur) is involved in the S. Typhimurium acid stress resistance that is 
induced by space analog culture (21). Thus, the use of the RWV as both an indicator 
of spaceflight trends in microbial response as well as a tool to understand possible 
mechanisms has been accepted in the scientific community. 
 
One stimulus that could impact spaceflight culture of microorganisms is the physical 
impact of fluid dynamics, specifically fluid shear. The potential of a fluid shear 
response was supported by spaceflight-analog studies of S. Typhimurium cultured in 
the RWV (81). In these experiments, a correlation was observed between the 
progressive addition of shear into the system and a decrease in microbial responses 
associated with culture in the RWV. The potential of a spaceflight-associated 
mechanotransductive response, which is the product of changes in physical forces on 
the cell membrane would not be without precedence, as shear forces have been 
demonstrated to impact microbial responses (82, 83). Indeed, a number of bacterial 
cytoskeletal structures, such as MreB (actin homolog) and FtsZ (tubulin homolog) have 
been identified (84). Taken together, this evidence suggests the responses, such as 
altered growth, observed with microorganisms resulting from spaceflight culture may 
be the result of the secondary effects found in liquid culture during spaceflight, such as 
very low fluid shear. 
 
An alternative stimulus that has been proposed was based upon differential gene 
expression data of both P. aeruginosa (50) and S. aureus (77). In both organisms 
evidence of low oxygen levels was detected that could have impacted the response of 
the microorganisms. 
 
As with spaceflight, understanding the biochemical responses of microorganisms to 
this environment provides insight into both the stimulus/stimuli and implications for 
crew health. In early studies, Fang et al. reported that culture in the RWV resulted in 
the reduction in production of β-lactam antibiotics by Streptomyces clavuligerus (85), 
reduction of microcin B17 (MccB17) production by E. coli (86), but no change in 
Gramicidin S production by Bacillus brevis (87). These findings suggest a possible 
difference in membrane structure, biochemical production of these compounds, or an 
alteration in the transport mechanism. 
5. Micro 5: Current microbial standards identifying microbial risk limits need to be 
updated and microbial requirements need to be developed to include new 
technologies and future mission scenarios. 
As mission scenarios are defined, the microbial requirements will continue to be 
reviewed and updated to ensure crew health and safety. Technology advancements will 
be monitored and evaluated for applicability.  
 
Spaceflight technology developed to study viral reactivation in astronauts has 
translated to Earth for use in medicine. Some physicians use this polymerase chain 
reaction (PCR) based technology to analyze for herpes viruses in saliva and other body 
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fluids (88). This technology is non-invasive, rapid, and highly accurate and has been 
shown to assist in the diagnosis of difficult cases and prevent misdiagnosis. 
 
V. Computer-Based Modeling and Simulation 
 
Computer-based modeling and simulations are not included in this risk.  
 
VI. Risk in context of Exploration Mission Operational Scenarios 
 
Current medical operations do not incorporate potential alterations in host-microorganism 
interactions, per se; however, the risk of infection is greatly minimized through current vehicle 
design and operational requirements. Vehicles and their systems are designed to maintain 
microbial concentrations at very conservative levels (eg, potable water below 50 CFU per mL). 
Operational activities are also designed to limit crew exposure, including preflight crew quarantine 
and stringent preflight/in-flight monitoring.  
 
As the risk of infectious disease is a function of the presence and characteristics of the agents, the 
dose-response of those agents, and the crew exposure to those agents, the risk of infectious disease 
during different mission scenarios varies depending on several potential factors, including mission 
duration, design of the environmental life support system, and continued/repetitive use of the 
facility. Any change in the risk of infectious disease attributed to spaceflight would have 
corresponding change in the vehicle design or operational activities. For example, if spaceflight 
induces changes in the concentration or virulence of opportunistic pathogens during a mission, 
appropriate adjustments in allowable microbial concentrations, housekeeping, or antibiotic 
provision may need to occur. 
VII.  Knowledge Gaps  
 
The Human Research Program has aligned the Knowledge Gaps of this risk to correspond with 
federal interagency guidelines for microbiological risk assessment outlined in USDA/FSIS/2012-
001 and EPA/100/J12/0016.   
 
These include: 
 Micro 1: We need to determine the efficacy of current countermeasures and the need for 
countermeasure development based on changes in microbial populations and 
characteristics. 
 Micro 2: We need to determine if spaceflight induces changes in diversity, concentration, 
and/or characteristics of medically significant microorganisms associated with the crew 
and environment aboard the International Space Station (ISS) that could affect crew health. 
                                                 
6 http://www.fsis.usda.gov/wps/wcm/connect/d79eaa29-c53a-451e-ba1c-
36a76a6c6434/Microbial_Risk_Assessment_Guideline_2012-001.pdf?MOD=AJPERES 
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 Micro 3: We need to determine which medically significant microorganisms display 
changes in the dose-response profiles in response to the spaceflight environment that could 
affect crew health. 
 Micro 4: We need to determine how physical stimuli specific to the spaceflight 
environment, such as microgravity, induce unique changes in the dose-response profiles of 
expected medically significant microorganisms. 
 Micro 5: Current microbial standards identifying microbial risk limits need to be updated 
and microbial requirements need to be developed to include new technologies and future 
mission scenarios. 
 
VIII. Conclusion  
 
Numerous spaceflight experiments have been conducted to investigate alterations in microbial 
responses resulting from culture during spaceflight and spaceflight-analogs. However, recent 
studies investigating spaceflight-associated alterations in microbial virulence have initiated the 
review and production of evidence to better understand the impact these alterations would have on 
the incidence of infectious disease during a spaceflight exploration mission. The preponderance of 
evidence indicates that alterations in microbial gene expression and phenotype (including 
virulence) are occurring; however, the clinical implications of such changes are still unclear. 
Greater knowledge is required including a better understanding of the mechanism behind unique 
spaceflight-associated microbial responses to determine how this environmental stimulus impacts 
various microorganisms, their diversity and concentration in the spacecraft and crew microbiome, 
their impact on the vehicle and crew, and their resistance to current mitigation and antibiotic 
regimens. This knowledge will enable us to determine requirements, guidelines, and processes for 
design and monitoring of the next generation vehicles.    
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APPENDIX A 
 
Microbial Responses Documented during Spaceflight 
 
Microorganism(s) / Flight Response to Spaceflight Reference 
Escherichia coli, Aerobacter 
aerogenes, and 
Staphylococcus 
Unmanned Satellite, 1960 
 Bacterial viability was unaffected by spaceflight 
conditions 
Zhukov-
Verezhnikov, 
1962(89) 
Escherichia coli 
Vostok 2, 1961 
 Variant colony type was noted and was 
determined to be the result of spaceflight factors 
Klemparskaya, 
1964(90) 
Escherichia coli 
Vostok 5 and 6, 1963 
 Increase in the levels of phage induction 
correlating with the duration of time spent in 
microgravity was noted 
Zhukov-
Verezhnikov, 1965; 
1966(91, 92) 
Escherichia coli and 
Salmonella enterica  serovar 
Typhimurium 
Biosatellite 2, 1967 
 Increased population density for both 
microorganisms 
Mattoni, 1968; 
1971(93, 94) 
Bacillus subtilis 
Apollo 16 and 17, 1972 
 Developmental process of spore formation was 
unaffected by spaceflight conditions 
Bucker, 1975(95) 
Bacillus subtilis 
Apollo-Soyuz Test Project, 
1975 
 Colony forming ability of spores was found to 
be reduced among spaceflight samples 
Facius, 1978(96) 
Escherichia coli and 
Staphylococcus aureus 
Salyut 6, 1977 – Salyut 7, 
1982 
 Both organisms displayed increased resistance 
to multiple antibiotics 
 Thickening of the cell wall in S. aureus 
Tixador, 1983; 
Tixador, 1985a;  
Tixador, 1985b; 
Lapchine, 1987(97-
100) 
Escherichia coli and 
Bacillus subtilis 
STS-61-A, Challenger, 1985 
 Increased conjugation (E. coli) 
 Increased growth kinetics (B. subtilis) 
Ciferi, 1988; 
Mennigmann, 
1986(101, 102) 
Escherichia coli and 
Bacillus subtilis 
STS-63, Discovery, 1995 
 Decreased lag growth phases 
 Increased exponential growth phases 
 Increased cell population 
Kacena, 1999 (38) 
Pseudomonas aeruginosa 
STS-95, Discovery, 1998 
 Documented biofilm formation in microgravity  McLean, 2001(103) 
Salmonella enterica  serovar 
Typhimurium  
STS-115, Atlantis, 2006 
 Increased virulence; in a murine infection 
model, spaceflight cultured organisms caused a 
reduced time-to-death, increased percent 
mortality, and decreased lethal dose required to 
kill 50% of the mice (LD50) as compared to 
ground control cultures 
 Differential gene and protein expression 
 Hfq identified as a possible regulator of the 
microgravity response  
Wilson, 2007 (15) 
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Microorganism(s) / Flight Response to Spaceflight Reference 
Pseudomonas aeruginosa 
STS-115, Atlantis, 2006 
 Differential gene and protein expression 
 Involvement of Hfq in the microgravity 
response 
Crabbe, 2011 (14) 
Candida albicans 
STS-115, Atlantis, 2006 
 Differential gene expression 
 Increased cell-aggregation genes and phenotype 
 No increase in virulence observed in a murine 
infection model 
Crabbe, 2013(13) 
Salmonella enterica  serovar 
Typhimurium  
STS-123, Endeavor, 2008 
 Increased virulence findings confirmed  
 Media ion concentration influences the 
spaceflight-related virulence response; when 
cultured in a modified growth medium, the 
spaceflight imparted increase in virulence was 
reduced to the level of ground controls 
 Differential gene and protein expression 
 Confirmation of Hfq as a potential regulator of 
the spaceflight response 
Wilson, 2008 (16) 
Pseudomonas aeruginosa 
STS-132, Atlantis, 2010 
STS-135, Atlantis, 2011 
 Increased number of viable cells 
 Increased biofilm biomass and thickness 
 Unique biofilm architecture not previously 
observed on Earth 
 Unique biofilm formation was dependent on 
flagella-drive motility  
Kim, 2013 (51, 54) 
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APPENDIX B 
 
Microbial Responses to Modeled Microgravity 
 
Microorganism  
Response to modeled microgravity within the 
RWV bioreactor Reference 
Salmonella enterica  
serovar 
Typhimurium 3339 
 Increased: virulence in a mouse model; resistance 
to acid, thermal, and osmotic stress; macrophage 
survival 
 Decreased: LPS production; resistance to oxidative 
stress; Hfq expression 
 Differential gene expression 
Nickerson, 2000 (20) 
Wilson, 2002 (21) 
Wilson, 2002 (104) 
Wilson, 2007(15) 
Pacello, 2012(105) 
Salmonella enterica  
serovar 
Typhimurium 14028 
 Increased: virulence in a mouse model and cellular 
invasion 
 Differential gene expression 
Chopra, 2006(106) 
Escherichia coli 
AMS6 
 Increased biofilm formation and resistance to 
osmotic, ethanol and antibiotic stress 
Lynch, 2006(75) 
Escherichia coli 
E2348/69 
 Increased intimin production Carvalho, 2005(107) 
Escherichia coli 
MG1655 
 Decreased growth 
 Differential gene expression 
Tucker, 2007 (73) 
Escherichia coli 
K12 
 Differential gene expression Vukanti, 2008(108) 
Escherichia coli 
083:H1 
 Increased resistance to thermal and oxidative stress 
and adhesion to epithelial cells 
Allen, 2008 (76) 
Pseudomonas 
aeruginosa PA01 
 Increased: biofilm formation; elastase production, 
and rhamnolipid production; alginate production; 
resistance to oxidative and thermal stress; Hfq 
expression 
 Differential gene expression 
Crabbe, 2008 (49) 
Crabbe, 2010 (50) 
Streptococcus 
pneumoniae TIGR4 
 Differential gene expression Allen, 2006 (109) 
Staphylococcus 
aureus N315 
 Increased: biofilm formation; susceptibility to 
whole blood  
 Decreased: growth; carotenoid production; 
resistance to oxidative stress; Hfq expression 
Castro, 2011 (77) 
Staphylococcus 
aureus RF1, RF6, 
RF11 
 Decreased: carotenoid production; hemolytic 
activity 
 Differential gene expression 
Rosado, 2010 (78) 
Staphylococcus 
aureus 25923 
 Increased: growth and membrane integrity Vukanti, 2012 (110) 
Yersina Pestis 
KIMD27 
 Decreased: Hela cell rounding Lawal, 2010 (111) 
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Microorganism  
Response to modeled microgravity within the 
RWV bioreactor Reference 
Haloferax 
mediterranei DSM 
1411 
 Increased: antibiotic resistance 
 Differential pigment production and protein 
expression 
Dornmayr-
Pfaffenhuemer, 
2011(112) 
Halococcus 
dombrowskii DSM 
14522 
 Decreased: cell aggregations 
 Differential pigment production and protein 
expression 
Dornmayr-
Pfaffenhuemer, 
2011(112) 
Saccharomyces 
cerevisiae BY4743 
 Increased: aberrant budding 
 Differential gene expression 
Purevdorj-Gage, 2006 
(113) 
Candida albicans 
SC5314 
 Increased: filamentous growth; biofilm formation; 
antimicrobial resistance 
 Differential gene expression 
Altenburg, 2008 (80) 
Searles, 2011 (114) 
Enterobacter cloacae 
ATCC23355 
 Decreased: resistance to acid and oxidative stress 
 Differential gene expression 
Soni, 2014 (115) 
Citrobacter freundii 
ATCC8090 
 Decreased: resistance to oxidative stress 
 Differential gene expression; Hfq expression 
Soni, 2014 (115) 
Serratia marcescens 
ATCC14041 
 Increased: resistance to acid stress Soni, 2014 (115) 
Streptococcus 
pyogenes 
 Decreased: growth; antibiotic resistance  
 Differential gene expression 
Kalpana, 2015 (116) 
Staphylococcus 
epidermidis 
ATCC12228 
 Increased: growth  Fajardo-Cavazos, 
2014 (117) 
Bacillus subtilis 
WN1532 
 Increased: growth; antibiotic resistance Fajardo-Cavazos, 
2014 (117) 
Rhinovius  Increased: virus (free and cell-associated) Long, 1998(118) 
Epstein-Barr virus  Decreased: viral protein expression 
(immunofluorescence) of host cells 
Long, 1999(119) 
Epstein-Barr virus  Microgravity alone decreased: apoptosis, cell death and 
DNA repair of host cells 
 Microgravity and radiation exposure increased: DNA 
damage and reactive oxygen species of host cells 
Brinley, 2013(120) 
Vibrio fischeri 
(symbiosis with host 
squid) 
 Increased: bacteria-induced apoptosis 
 Decreased: host innate immune response 
Foster, 2013(121) 
 
